The weekly litigation news digest is live. Subscribe now

IP Verse

The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. - 1:25-cv-13865

The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. (Case No. 1:25-cv-13865), filed on Dec 16, 2025 in the District Court, D. Massachusetts involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:25-cv-13865
Filing Date
Dec 16, 2025
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Massachusetts
Nature of Suit
Patent

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Alnylam U.S., Inc. -
The Board of Regents of the University of Texas System -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Sep 24, 2025Unopposed Motion for leave to File Sealed Document (Attachments: # 1 Proposed Order, # 2 Exhibit 1, # 3 Exhibit 4, # 4 Exhibit 5) (Kadivar, Samoneh) (Entered: 09/24/2025)PACER Document
Sep 29, 2025ORDER GRANTING 71 Motion for Leave to File Sealed Document Signed by Judge David A. Ezra. (cc3) (Entered: 09/29/2025)PACER Document
Sep 30, 2025Minute Entry for proceedings held before Judge Mark Lane: TELEPHONIC STATUS CONFERENCE held on 9/30/2025. Written order forthcoming. (Minute entry documents are not available electronically) (Court Reporter web ex.)(cc3) (Entered: 09/30/2025)PACER Document
Oct 1, 2025REPLY to Response to Motion, filed by The Board of Regents of the University of Texas System, re 66 MOTION to Strike Inequitable Conduct Allegations filed by Plaintiff The Board of Regents of the University of Texas System (Hurt, Christian) (Entered: 10/01/2025)PACER Document
Oct 1, 2025Response in Opposition to Motion, filed by The Board of Regents of the University of Texas System, re 68 Opposed MOTION to Stay Case (Alnylam's Opposed Motion to Continue to Stay this Case Pending Resolution of its Renewed Motion to Dismiss and/or Transfer) filed by Defendant Alnylam Pharmaceuticals Inc., Defendant Alnylam U.S., Inc. (Attachments: # 1 Declaration of Christian Hurt ISO of Response, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Hurt, Christian) (Entered: 10/01/2025)PACER Document
Oct 2, 2025SECOND AMENDED SCHEDULING ORDER: Markman Hearing set for 4/27/2026 at 9:00 AM before Judge David A. Ezra, ADR Report Deadline due by 12/10/2025, Discovery due by 12/22/2026, Joinder of Parties due by 2/23/2026. Signed by Judge Mark Lane. (cc3) (Entered: 10/02/2025)PACER Document
Oct 7, 2025Transcript filed of Proceedings held on September 30, 2025, Proceedings Transcribed: Telephonic Status Conference. Parties are notified of their duty to review the transcript to ensure compliance with the FRCP 5.2(a)/FRCrP 49.1(a). A copy may be purchased from the court reporter or viewed at the clerk's office public terminal. If redaction is necessary, a Notice of Redaction Request must be filed within 21 days. If no such Notice is filed, the transcript will be made available via PACER without redaction after 90 calendar days. The clerk will mail a copy of this notice to parties not electronically noticed (Balcombe, April) (Entered: 10/07/2025)PACER Document
Oct 8, 2025REPLY to Response to Motion, filed by Alnylam Pharmaceuticals Inc., Alnylam U.S., Inc., re 68 Opposed MOTION to Stay Case (Alnylam's Opposed Motion to Continue to Stay this Case Pending Resolution of its Renewed Motion to Dismiss and/or Transfer) filed by Defendant Alnylam Pharmaceuticals Inc., Defendant Alnylam U.S., Inc. (Attachments: # 1 Schickel Declaration, # 2 Exhibit 2)(Kadivar, Samoneh) (Entered: 10/08/2025)PACER Document
Oct 8, 2025Response in Opposition to Motion, filed by The Board of Regents of the University of Texas System, re 70 Opposed MOTION to Dismiss (Alnylam's Opposed Renewed Motion to Dismiss the Complaint for Improper Venue or in the Alternative Transfer under Rule 12(b)(3)) filed by Defendant Alnylam Pharmaceuticals Inc., Defendant Alnylam U.S., Inc. (Attachments: # 1 Declaration of Christian Hurt ISO of Response In Opposition, # 2 EX 1 - SEALED DOCUMENT, # 3 Ex. 2, # 4 Ex. 3 - SEALED DOCUMENT, # 5 Ex. 4 - SEALED DOCUMENT, # 6 Ex. 5 - SEALED DOCUMENT, # 7 Ex. 6 - SEALED DOCUMENT, # 8 Ex. 7 - SEALED DOCUMENT, # 9 Ex. 8 - SEALED DOCUMENT, # 10 EX 9 - SEALED DOCUMENT, # 11 EX 10 - SEALED DOCUMENT, # 12 Ex. 11 - SEALED DOCUMENT, # 13 Ex 12, # 14 Ex 13 - SEALED DOCUMENT, # 15 Ex 14 - SEALED DOCUMENT, # 16 Ex 15 - SEALED DOCUMENT, # 17 Ex 16 - SEALED DOCUMENT, # 18 Ex 17 - SEALED DOCUMENT, # 19 Ex 18, # 20 Ex 19, # 21 Ex 20, # 22 Ex 21, # 23 Ex 22, # 24 Ex 23 - SEALED DOCUMENT, # 25 Ex 24, # 26 Ex 25, # 27 Ex 26, # 28 Ex 27, # 29 Ex 28, # 30 Ex 29, # 31 Ex 30, # 32 Ex 31)(Hurt, Christian) (Entered: 10/08/2025)PACER Document
Oct 8, 2025Unopposed Motion for leave to File Sealed Document (Attachments: # 1 EX A - SEALED DOCUMENT, # 2 EX 1 - SEALED DOCUMENT, # 3 EX 3 - SEALED DOCUMENT, # 4 EX 4 - SEALED DOCUMENT, # 5 EX 5 - SEALED DOCUMENT, # 6 EX 6 - SEALED DOCUMENT, # 7 EX 7 - SEALED DOCUMENT, # 8 EX 8 - SEALED DOCUMENT, # 9 EX 9 - SEALED DOCUMENT, # 10 EX 10 - SEALED DOCUMENT, # 11 EX 11 - SEALED DOCUMENT, # 12 EX 13 - SEALED DOCUMENT, # 13 EX 14 - SEALED DOCUMENT, # 14 EX 15 - SEALED DOCUMENT, # 15 EX 16 - SEALED DOCUMENT, # 16 EX 17 - SEALED DOCUMENT, # 17 EX 23 - SEALED DOCUMENT, # 18 Proposed Order) (Hurt, Christian) (Entered: 10/09/2025)PACER Document
Oct 9, 2025ORDER GRANTING 80 Motion for Leave to File Sealed Document Signed by Judge David A. Ezra. (cc3) (Entered: 10/09/2025)PACER Document
Oct 15, 2025REPLY to Response to Motion, filed by Alnylam Pharmaceuticals Inc., Alnylam U.S., Inc., re 70 Opposed MOTION to Dismiss (Alnylam's Opposed Renewed Motion to Dismiss the Complaint for Improper Venue or in the Alternative Transfer under Rule 12(b)(3)) filed by Defendant Alnylam Pharmaceuticals Inc., Defendant Alnylam U.S., Inc. (Attachments: # 1 Schickel Declaration, # 2 Exhibit 8, # 3 Exhibit 9, # 4 Exhibit 10)(Kadivar, Samoneh) (Entered: 10/15/2025)PACER Document
Oct 15, 2025Unopposed Motion for leave to File Sealed Document (Attachments: # 1 Proposed Order, # 2 Unredacted Reply Brief in Support of Motion 70, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10) (Kadivar, Samoneh) (Entered: 10/15/2025)PACER Document
Oct 16, 2025ORDER GRANTING 83 Motion for Leave to File Sealed Document Signed by Judge David A. Ezra. (cc3) (Entered: 10/17/2025)PACER Document
Nov 4, 2025ORDER GRANTING 68 Motion to Stay Case. Signed by Judge David A. Ezra. (cc3) (Entered: 11/05/2025)PACER Document
Dec 15, 2025Report on Patent/Trademark sent to U.S. Patent and Trademark Office. (cnr) (Entered: 12/15/2025)PACER Document
Dec 16, 2025ELECTRONIC NOTICE of Case Assignment. Judge Brian E. Murphy assigned to case. If the trial Judge issues an Order of Reference of any matter in this case to a Magistrate Judge, the matter will be transmitted to Magistrate Judge Donald L. Cabell. (Danieli, Chris) (Entered: 12/16/2025)PACER Document
Dec 16, 2025Notice: Counsel who filed an appearance in this case prior to its transfer must refer to Local Rule 83.5.3(h) Practice by Persons Not Members of the Bar on how to proceed as an attorney in this court. General Information for Attorneys can be found here. (Danieli, Chris) (Entered: 12/16/2025)PACER Document
Dec 17, 2025NOTICE OF HEARING: Status Conference set for 1/12/2026 at 12:00 p.m. remotely by Zoom before Judge Brian E. Murphy. In preparation for this Status Conference, the parties shall file a Joint Status Report no later than 1/7/2026, indicating the present status of the case and proposing a new schedule to move forward given the brief stay previously imposed by Judge David A. Ezra in the Western District of Texas. (BIB) (Entered: 12/17/2025)PACER Document